“One Belt and One Road” International Ophthalmic Artificial Intelligence Research and Development Alliance, “Medical Artificial Intelligence Database Management Specification Program Revision Seminar in 2019” Expert Panel, National Key Research and Development Program of China “Development and Clinical Trials of Artificial Intelligence Diagnostic System for Blindness-causing Diseases, Teratogenic Abnormalities, Life Threatening Disorders” Project Team, the Science and Technology Planning Projects of Guangdong Province “Construction of Medical Data Labeling Technique System, General Dataset, and Intelligent Application Platform” Project Team
DOI: 10.3760/cma.j.issn.2095-0160.2019.12.001
Published 2019-12-10
Cite as Chin J Exp Ophthalmol, 2019,37(12): 937-941.
Medical artificial intelligence (AI) is an important technical strategy to promote medical supply-side reforms and national development.Images of ophthalmic disease are the important data resource for the development and application of ophthalmic AI-aided diagnosis and treatment systems based on medical big data.In order to establish an AI ophthalmic disease imaging database that can be effectively utilized as big data resources, improve the efficiency of ophthalmic AI research, and promote the development of ophthalmic AI research based on big data in the new era, the International Ophthalmic Artificial Intelligence Research and Development Alliance drafted and adopted the “Guidelines for image quality assessment of artificial intelligence ophthalmic diseases imaging database” . Specifications and recommendations of the image quality assessment for the AI ophthalmic disease image database were formulated on data types, data related information, data quality, informed consent, and data sharing.
Key words:
Artificial intelligence; Ophthalmic disease; Database; Data quality
Contributor Information
“One Belt and One Road” International Ophthalmic Artificial Intelligence Research and Development Alliance
“Medical Artificial Intelligence Database Management Specification Program Revision Seminar in 2019” Expert Panel
National Key Research and Development Program of China “Development and Clinical Trials of Artificial Intelligence Diagnostic System for Blindness-causing Diseases, Teratogenic Abnormalities, Life Threatening Disorders” Project Team
the Science and Technology Planning Projects of Guangdong Province “Construction of Medical Data Labeling Technique System, General Dataset, and Intelligent Application Platform” Project Team
(Read 99 times, 1 visits today)